Patents by Inventor Park Min SHIN

Park Min SHIN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for diagnosing cancer using lectin
    Patent number: 8623667
    Abstract: The present invention relates to a method for diagnosing cancer using information on aberrant glycosylation of glycoproteins, which is related with cancer progression. More particularly, the present invention relates to a peptide marker for cancer diagnosis and a method for diagnosing cancer using the peptide marker, wherein glycoproteins aberrantly glycosylated due to cancer incidence and progression is isolated using lectin; and marker peptides generated by hydrolysis of the glycoproteins isolated by the lectin is selected and quantified.
    Type: Grant
    Filed: May 3, 2012
    Date of Patent: January 7, 2014
    Assignee: Korea Basic Science Institute
    Inventors: Yeong Hee Ahn, Jong Shin Yoo, Park Min Shin, Eun Sun Ji
  • POLYPEPTIDE MARKERS FOR THE DIAGNOSIS OF CANCERS, AND METHODS FOR THE DIAGNOSIS OF CANCERS USING THE SAME
    Publication number: 20130261015
    Abstract: A method for diagnosing cancer using information on aberrant glycosylation of glycoproteins, which is related with cancer progression. More particularly, the present invention relates to a peptide marker for cancer diagnosis and a method for diagnosing cancer using the peptide marker, wherein glycoproteins aberrantly glycosylated due to cancer incidence and progression is isolated using lectin; and marker peptides generated by hydrolysis or the glycoproteins isolated by the lectin is selected and quantified.
    Type: Application
    Filed: March 26, 2013
    Publication date: October 3, 2013
    Applicant: Korea Basic Science Institute
    Inventors: Yeong Hee AHN, Jong Shin YOO, Park Min SHIN
  • METHOD FOR DIAGNOSING CANCER USING LECTIN
    Publication number: 20120282628
    Abstract: The present invention relates to a method for diagnosing cancer using information on aberrant glycosylation of glycoproteins, which is related with cancer progression. More particularly, the present invention relates to a peptide marker for cancer diagnosis and a method for diagnosing cancer using the peptide marker, wherein glycoproteins aberrantly glycosylated due to cancer incidence and progression is isolated using lectin; and marker peptides generated by hydrolysis of the glycoproteins isolated by the lectin is selected and quantified.
    Type: Application
    Filed: May 3, 2012
    Publication date: November 8, 2012
    Applicant: KOREA BASIC SCIENCE INSTITUTE
    Inventors: Yeoung Hee AHN, Jong Shin YOO, Park Min SHIN, Eun Sun JI